Alzheimer's Equities

Eisai and Biogen's Joint Development, Lecanemab, Progresses in EU Regulatory Review for Alzheimer's Treatment Jul 27, 2024

Neumora Therapeutics Sets Sights on Alzheimer's with NMRA-511 Clinical Trial Jun 21, 2024